+1 877 705 191424 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID06308328

Observational Study on Predicting Radiation-Induced Oropharyngeal Mucositis Using a New Mucosal Contouring Method in Nasopharyngeal Carcinoma Patients

Led by Nanfang Hospital, Southern Medical University · Updated on 2024-03-13

718

Participants Needed

10

Research Sites

8 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying a new mucosal contouring method to predict radiation-induced oropharyngeal mucositis in patients with nasopharyngeal carcinoma NPC. This condition, which causes swallowing-induced breakthrough pain, greatly affects patients quality of life during radiotherapy. Previous prediction models using oral cavity or mucosa surface contouring were not satisfactory, so this study aims to further evaluate a method based on mucosal areas linked to breakthrough pain in a real-world, multicenter observational setting. This observational study will follow patients with locally advanced NPC undergoing radical radiotherapy or chemoradiotherapy. The study focuses on assessing how well the mucosal delineation method predicts the occurrence and severity of oropharyngeal mucositis by tracking swallowing-induced breakthrough pain. There are no investigational treatments involved instead, patients are observed and data is collected during their standard care. Participants will have their oral or oropharyngeal mucositis severity and swallowing pain recorded continuously throughout their treatment. Researchers will analyze the predictive models performance by measuring accuracy, sensitivity, specificity, and other statistical values over up to three years. The study will help improve risk assessment and early intervention for mucositis in NPC patients, with all data collected during their regular clinical visits.

CONDITIONS

Brief Title

A Real-world Observational Study of a Mucosal Contouring Method for Radiation-induced Oropharyngeal Mucositis

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Provide informed written consent.
  • Be 18 years of age or older.
  • Have a confirmed diagnosis of nasopharyngeal carcinoma.
  • Currently undergoing radical radiotherapy or chemoradiotherapy.
  • Have complete and continuous records of oral or oropharyngeal mucositis grading and self-reported swallowing-induced breakthrough pain.
Not Eligible

You will not qualify if you...

  • Have poor oral hygiene, untreated dental or periodontal diseases, or metal dental restorations.
  • Have untreated or unresolved unstable heart diseases requiring treatment.
  • Have poorly controlled diabetes mellitus.
  • Have a body mass index (BMI) less than 18.5.
  • Be assessed by researchers as unsuitable to participate in the study.

Research Team

J

Jian Guan, Ph.D.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here